Indiana Biosciences Research Institute Opens Office at Notre Dame

Author: Christy Denault


First Satellite Location at Innovation Park to Foster New Collaborations

The Indiana Biosciences Research Institute (IBRI) opens its first satellite location at Innovation Park on the campus of the University of Notre Dame. The celebration will include a presentation to students of the ESTEEM graduate entrepreneurship program and a reception with faculty, staff, and local government officials.

“Collaboration is the lifeblood of innovation, and we are pleased to be extending our relationship with the University of Notre Dame,” said David Broecker, President and CEO of IBRI. “The opening of this satellite location will bring us into contact with the researchers, entrepreneurs, and innovators and their ideas, sparking new opportunities to collaborate Innovation Park is the perfect place for us to connect with the Notre Dame community.”

The IBRI began working with the University of Notre Dame in October last year, when Notre Dame computer science and engineering professor Nitesh Chawla was named s Visiting Fellow of the IBRI. He also serves as the Interim Director of the Applied Data Sciences Center. Chawla is the director of both the iCeNSA research center on network and data sciences and the Data Inference Analytics and Learning Lab (DIAL) at the University of Notre Dame. 

“We are excited to have the IBRI as an integral partner of Innovation Park and our new Idea Center,” said Bryan Ritchie. “Our vision depends on Notre Dame connecting with the great companies, and organizations like the IBRI that can help spur growth and development of the innovation ecosystem around Notre Dame and South Bend.”

Mike Pugia, IBRI Research Fellow and Director of the Single Cell Bioanalytics Center, will split his time between IBRI headquarters in Indianapolis and the satellite office at Innovation Park. Pugia is currently working with researchers at Notre Dame on the development of new analytical technologies.

The IBRI was established in 2013. Initial funding of $50 million came from the State of Indiana, Lilly Endowment, Eli Lilly and Company, Roche Diagnostics, Dow AgroSciences, Indiana University Health, and the Indiana University School of Medicine.  Additional funding has come from Cook, Lilly Foundation, and the Lilly Endowment. The Institute moved into its current headquarters in October 2015 and will be the anchor tenant in the 16Tech Innovation District, which plans to break ground later this year.

About Indiana Biosciences Research Institute

The Indiana Biosciences Research Institute (IBRI) is an independent, nonprofit discovery science and applied research institute focused on innovation targeting cardio-metabolic diseases, diabetes and poor nutrition. Inspired by the state and Indiana’s leading life sciences companies, research universities and philanthropic community, the IBRI is building a world-class organization of researchers, innovators, and entrepreneurs that will catalyze scientific discovery and its application, resulting in improved health outcomes for patients. For more information about IBRI and donation or collaboration opportunities, please visit or follow us on Twitter.


Originally published by Christy Denault at on March 03, 2017.